ClinicalTrials.gov
ClinicalTrials.gov Menu

Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (EAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01784562
Expanded Access Status : No longer available
First Posted : February 6, 2013
Last Update Posted : January 6, 2016
Sponsor:
Information provided by (Responsible Party):
Bayer